越秀证券：每日晨报-20241121

Market Performance - The Hang Seng Index closed at 19,705, up 0.21% for the day and up 15.59% year-to-date [1] - The Hang Seng Tech Index rose by 0.41% to 4,413, with a year-to-date increase of 17.24% [1] - The Shanghai Composite Index increased by 0.66% to 3,367, with a year-to-date rise of 13.21% [1] Key Economic Indicators - The UK's core inflation rate rose by 0.4% month-on-month in October, exceeding the previous 0.1% and the forecast of 0.3% [3][6] - China's biopharmaceutical company, China Biologic Products Holdings (01177), acquired a 4.91% stake in Lixin Pharmaceutical and signed a strategic cooperation agreement [3][9] - NIO Inc. (09866.HK) reported a widened non-GAAP adjusted net loss of 4.403 billion RMB for the third quarter [3][10] Company Specifics - NIO's total revenue for the third quarter was 18.674 billion RMB, a year-on-year decrease of 2.1%, with vehicle sales revenue down 4.1% [10] - NIO delivered 61,855 vehicles in the third quarter, an increase of 11.6% year-on-year, and expects fourth-quarter deliveries to be between 72,000 and 75,000 vehicles [11] - China Biologic's investment in Lixin Pharmaceutical aims to accelerate the development of innovative antibody drugs in mainland China [9] IPO Information - Upcoming IPO for SF Express is scheduled for November 27, 2024, with a price range of 32.3-36.3 HKD [25] - Recent IPOs include Guofu Hydrogen Energy, which debuted on November 15, 2024, with a first-day performance of 20% [25]